xmlns:xalan=”https://xml.apache.org/xalan”>FONTES:
xmlns:xalan=”https://xml.apache.org/xalan”>Mayo Clinic: “hiperplasia Benigna da próstata:” Definição “hiperplasia Benigna da próstata: Tratamentos e Drogas”, “cirurgia Minimamente invasiva: Definição.”
xmlns:xalan=”https://xml.apache.org/xalan “>Urology Care Foundation: “What Are the Symptoms of BPH?””Benignal Prostatic Hyperplasia (BPH): Surgery,” “BPH: Minimally Invasive cirurgias,” “What is Transurethral Electroevaporation of the próstata (TUVP)?,”
xmlns:xalan=”https://xml.apache.org/xalan”>UCLA Health: “Conditions Treated: BPH.”
xmlns:xalan=”https://xml.apache.org/xalan”>U.S. Food & Drug Administration: “5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer.”
xmlns:xalan=”https://xml.apache.org/xalan”>National Institutes of Health, National Center for Complementary and Integrative Health: “Saw Palmetto.”
xmlns:xalan=”https://xml.apache.org/xalan”>FDA website.,
xmlns:xalan=”https://xml.apache.org/xalan”>American Urological Association: “Benign Prostatic Hyperplasia (BPH): A Patient’s Guide,” “Benign Prostatic Hyperplasia (BPH), Clinical Guidelines.”
xmlns:xalan=”https://xml.apache.org/xalan”>Agency for Healthcare Policy Research.
xmlns:xalan=”https://xml.apache.org/xalan”>William Jaffe, MD, professor of urology, Temple University School of Medicine, Philadelphia.,
xmlns:xalan=”https://xml.apache.org/xalan”>National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC): “Prostate Enlargement: Benign Prostatic Hyperplasia.”
xmlns:xalan=”https://xml.apache.org/xalan”>BJU International: “High-grade prostate cancer and finasteride.”
xmlns:xalan=”https://xml.apache.org/xalan”>Winchester Hospital: “Health Library: Saw Palmetto”
xmlns:xalan=”https://xml.apache.org/xalan”>Casabé A, Roehrborn CG, Da Pozzo LF, et al., “Eficácia e segurança da co-administração de tadalafil uma vez por dia com finasterida durante 6 meses em homens com sintomas do tracto urinário inferior e aumento da próstata secundário a hiperplasia prostática benigna.”J Urol.De 2014;191:727-733
xmlns:xalan=”https://xml.apache.org/xalan”>Porst H, Kim ED, Casabé AR, et al. “Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benigne prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.”Eur Urol.2011;60:1105-1113.